The Lee Kong Chian School of Medicine (LKCMedicine) trains doctors who put patients at the centre of their exemplary care. The School, which offers both undergraduate and graduate programmes, is named after local philanthropist Tan Sri Dato Lee Kong Chian. Established in 2010 by Nanyang Technological University, Singapore, in partnership with Imperial College London, LKCMedicine aims to be a model for innovative medical education and a centre for transformative research. The School's primary clinical partner is the National Healthcare Group, a leader in public healthcare recognised for the quality of its medical expertise, facilities and teaching. The School is transitioning to an NTU medical school ahead of the 2028 successful conclusion of the NTU-Imperial partnership to set up a Joint Medical School. In August 2024, we welcomed our first intake of the NTU MBBS programme, that has been recently enhanced to include themes like precision medicine and Artificial Intelligence (AI) in healthcare, with an expanded scope in the medical humanities. Graduates from the five-year undergraduate medical degree programme will have a strong understanding of the scientific basis of medicine, with an emphasis on technology, data science and the humanities.
The Nutrition, Metabolism and Health Programme is addressing one of the world's most pressing healthcare issue: Over nutrition driven chronic diseases. The key objectives are to support efforts to elucidating the molecular basis of type-2 diabetes, metabolic syndrome, including fatty liver disease and to track changes in inflammatory signatures and states from healthy to metabolically imbalanced phenotypes. Our mission is to understand the developmental and environmental basis of obesity, diabetes, related gut, liver and metabolic disorders and to translate this understanding into disease alleviation and prevention.
We are seeking a Research Associate. The role will focus on the development of novel therapeutic approaches for late and end-stage liver disease, including liver cancer. The candidate will conduct in vivo and in vitro validation work, as well as novel liquid biopsy derived biomarker discovery. Furthermore, she or he will closely work with our clinical partners and process and analyze human samples. The focus will be on translational impact.
Key Responsibilities:
Required educational qualification, experience, skills and competencies:
Hiring Institution: LKC
Tagged as: Life Sciences
Research Officer, Fermentation Biocatalysis and Downstream Processing (SIFBI) We are seeking candidates for the position of Research Officer for the...
ApplyScientist II In Molecular Biology As part of the Thermo Fisher Scientific team, you'll discover meaningful work that makes a...
ApplyJob Title Work Schedule: Standard (Mon-Fri) Environmental Conditions: Cold Room/Freezers -22degreesF/-6degrees C, Laboratory Setting, Office, Some degree of PPE (Personal...
ApplyDeputy Director (Data Analyst), DTID The Digital Transformation, Innovation and Data Division helps the organisation make better decisions, work efficiently,...
ApplyResearch Scientist The Alibaba-NTU Global e-Sustainability CorpLab (ANGEL) represents a key collaboration between Alibaba Group and Nanyang Technological University (NTU)....
ApplyResearch Associate We are looking for a Research Associate to conduct the research for the project entitled “Manual Assembly Job...
ApplyPlease visit ntu.wd3.myworkdayjobs.com.
Don't forget to mention that you found the position on jobRxiv!
